+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Viscosupplementation Market (By Procedure – Single Injection, Three Injection & Five Injection; By Region – North America, Europe & Asia Pacific) Outlook 2025

  • ID: 4806828
  • Report
  • July 2019
  • Region: Global, North America, Europe, Asia Pacific
  • 74 Pages
  • Rockville Research

FEATURED COMPANIES

  • Anika Therapeutics, Inc.
  • Sanofi Genzyme
  • Seikagaku Corporation
  • Smith & Nephew Plc
  • MORE

Global viscosupplementation market has been witnessing the advent of combination therapeutic products, which is already utilized in the treatment of various diseases. These products have been relatively new entrants in viscosupplement palliative knee osteoarthritis treatment which offers promising future prospects.

The report “Global Viscosupplementation Market (By Procedure - Single Injection, Three Injection & Five Injection; By Region - North America, Europe & Asia Pacific) Outlook 2025” provides an in-depth analysis of global viscosupplementation market with a focus on major procedures Single Injection, Three Injection & Five Injection. Geographical analysis is done across leading markets in regions such as North America, Europe & Asia Pacific.

The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market specific growth opportunities in global viscosupplementation market. The report has been segmented as follows:-

Geographical Coverage

  • North America - The US
  • Europe
  • Asia Pacific

Key Vendors

  • Sanofi Genzyme
  • Anika Therapeutics, Inc.
  • Seikagaku Corporation
  • Zimmer Biomet Holdings, Inc.
  • Smith & Nephew plc
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Anika Therapeutics, Inc.
  • Sanofi Genzyme
  • Seikagaku Corporation
  • Smith & Nephew Plc
  • MORE

1. Executive Summary

2. Research Methodology

3. Osteoarthritis
3.1 Overview
3.1.1 Symptoms
3.1.2 Diagnosis
3.2 Treatment
3.2.1 Corticosteroids
3.2.2 Hyaluronic Acid Injections
3.2.3 Viscosupplementation

4. Viscosupplementation
4.1 Overview
4.1.1 Synthesis
4.2 Procedure
4.2.1 Single Injection
4.2.2 Three Injection
4.2.3 Five Injection
4.3 Applications

5. Market Analysis
5.1 Market Sizing (Actual & Forecasted)
5.2 Market Share Analysis
5.2.1 Market Share by Procedure Type
5.2.2 Market Share by Hyaluronic Acid Type
5.2.3 Market Share by Application
5.2.4 Market Share by End-Users
5.2.5 Market Share by Region

6. Market Segmentation - Procedure
6.1 Single injection
6.1.1 Market Size by Value (Actual & Forecasted)
6.2 Three injection
6.2.1 Market Size by Value (Actual & Forecasted)
6.3 Five injection
6.3.1 Market Size by Value (Actual & Forecasted)

7. Regional Analysis
7.1 North America
7.1.1 Market Sizing (Actual & Forecasted)
7.1.2 The US
7.1.2.1 Market Size by Value (Actual & Forecasted)
7.1.2.2 Market Size by Volume (Actual & Forecasted)
7.1.2.3 Market Share by Product
7.2 Asia Pacific
7.2.1 Market Sizing (Actual & Forecasted)
7.3 Europe
7.3.1 Market Sizing (Actual & Forecasted)

8. Market Dynamics
8.1 Industry Trends & Developments
8.1.1 Advent of Combination Therapeutic Products
8.1.2 Launch of New Products
8.1.3 Rise in Number of Distribution Agreements
8.2 Growth Drivers
8.2.1 Increasing Geriatric Population
8.2.2 Prevalence of Arthritis
8.2.3 High Demand from Emerging Nations
8.2.4 Rising Public Awareness
8.3 Challenges
8.3.1 Stringent Regulations
8.3.2 Unfavorable Reimbursement Policies
8.3.3 Adverse Side-Effects

9. Competitive Landscape
9.1 Financial Analysis
9.2 Products Portfolio
9.3 Market Share Analysis

10. Company Profiles
10.1 Sanofi Genzyme
10.2 Anika Therapeutics, Inc.
10.3 Seikagaku Corporation
10.4 Zimmer Biomet Holdings Inc.
10.5 Smith & Nephew Plc

List of Figures
Figure 1: Research Methodology
Figure 2: Treatment Paradigm of Osteoarthritis
Table 1: Viscosupplementation Indication by Symptomatic Joint
Table 2: FDA Approved HA Products
Table 3: Commonly Used Hyaluronic Acid Preparations for IA Viscosupplementation
Table 4: Hyaluronic Acid Products by Source
Figure 3: Global Viscosupplementation Market Size by Value, 2017-25E (US$ Billions)
Figure 4: Global Viscosupplementation Market Share by Procedure Type (2018)
Figure 5: Global Viscosupplementation Market Share by Hyaluronic Acid Type (2018)
Figure 6: Global Viscosupplementation Market Share by Application (2018)
Figure 7: Global Viscosupplementation Market Share by End-Users (2018)
Figure 8: Global Viscosupplementation Market Share by Region (2018)
Figure 9: Global Viscosupplementation – Single Injection Market Size by Value, 2017-25E (US$ Millions)
Figure 10: Global Viscosupplementation – Three Injection Market Size by Value, 2017-25E (US$ Millions)
Figure 11: Global Viscosupplementation – Five Injection Market Size by Value, 2017-25E (US$ Millions)
Figure 12: North America Viscosupplementation Market Size by Value, 2017-25E (US$ Billions)
Figure 13: The US Viscosupplementation Market Size by Value, 2013-25E (US$ Millions)
Figure 14: The US Viscosupplementation Market Size by Volume, 2013-25E (#Treatment in Millions)
Figure 15: The US Viscosupplementation Market Share by Product (2018)
Figure 16: Asia Pacific Viscosupplementation Market Size by Value, 2017-25E (US$ Billions)
Figure 17: Europe Viscosupplementation Market Size by Value, 2017-25E (US$ Billions)
Table 5: Distribution Agreements in Global Viscosupplementation Industry
Figure 18: Global Ageing (65 and above) Population, 2013-18 (Millions)
Figure 19: Prevalence of Osteoarthritis by Age & Sex, 2017-18
Figure 20: Global Osteoarthritis Incidences, 2014-18 (Millions)
Table 6: Global Viscosupplementation Market Players Revenue Comparison, FY2016-FY2020E (US$ Millions)
Table 7: Global Viscosupplementation Market Players Financial Analysis (FY2019E)
Table 8: Global Viscosupplements – Single Injection Products Comparison (2018)
Table 9: Global Viscosupplements – Muliple Injection Products Comparison (2018)
Table 10: Physical Properties of Viscosupplements
Figure 21: The US Viscosupplementation Market Share by Competitors, 2013-2020E (%)
Figure 22: The US Viscosupplementation – Single Injection Market Share by Companies (2018)
Figure 23: The US Viscosupplementation – Single Injection Market Share by Companies (2018)
Figure 24: Sanofi Revenue by Business Segment (FY2018)
Figure 25: Sanofi Net Sales, FY2015-FY2019E (US$ Billions)
Figure 26: Anika Therapeutics, Inc. Revenue by Business Segment (FY2019E)
Figure 27: Anika Therapeutics, Inc. Net Sales, FY2015-FY2021E (US$ Millions)
Figure 28: Seikagaku Corporation Revenue by Business Segment (FY2018)
Figure 29: Seikagaku Corporation Net Sales, FY2015-FY2019E (US$ Billions)
Figure 30: Zimmer Biomet Holdings Inc. Revenue by Business Segment (FY2019E)
Figure 31: Zimmer Biomet Holdings Inc. Net Sales, FY2015-FY2019E (US$ Billions)
Figure 32: Smith & Nephew Plc Revenue by Business Segment (FY2018)
Figure 33: Smith & Nephew Plc Net Sales, FY2015-FY2019E (US$ Billions)

Note: Product cover images may vary from those shown
  • Anika Therapeutics, Inc.
  • Sanofi Genzyme
  • Seikagaku Corporation
  • Smith & Nephew Plc
  • Zimmer Biomet Holdings Inc.
Note: Product cover images may vary from those shown
Adroll
adroll